Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Wigs significantly improve the well-being of people with severe hair loss.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Platelet-Rich Plasma treatment has limited and temporary effects on severe Alopecia Areata and does not prevent relapses.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

The effectiveness of alternative treatments for alopecia areata is uncertain and needs more research.

A young girl developed unusually long eyelashes with a hair loss condition without other health issues or medication causes.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

A gluten-free diet does not help hair regrowth in celiac disease patients with alopecia areata.

Researchers identified a new hair loss pattern called "sisaipho type," where hair is lost across the scalp except around the edges.

Triamcinolone can regrow hair in alopecia areata, but the effect is temporary.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

New therapies for alopecia areata show potential but need more research.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Trichotillomania is often misdiagnosed as alopecia areata and can be treated effectively with N-acetylcysteine and psychotropic drugs.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.